MDACT: A New Principle of Adjunctive Cancer Treatment Using Combinations of Multiple Repurposed Drugs, with an Example Regimen

MDACT: A New Principle of Adjunctive Cancer Treatment Using Combinations of Multiple Repurposed Drugs, with an Example Regimen

In part one of this two-part paper, we present eight principles that we believe must be considered for more effective treatment of the currently incurable cancers. These are addressed by multidrug adjunctive cancer treatment (MDACT), which uses multiple repurposed non-oncology drugs, not primarily t...

Full description

Bibliographic Details
Main Authors: Richard E. Kast, Alex Alfieri, Hazem I. Assi, Terry C. Burns, Ashraf M. Elyamany, Maria Gonzalez-Cao, Georg Karpel-Massler, Christine Marosi, Michael E. Salacz, Iacopo Sardi, Pieter Van Vlierberghe, Mohamed S. Zaghloul, Marc-Eric Halatsch
Format: Article
Language:English
Published: MDPI AG 2022-05-01
Series:Cancers
Subjects:
cholangiocarcinoma
colon cancer
CUSP9v3
glioblastoma
lung cancer
multidrug regimen
Online Access:https://www.mdpi.com/2072-6694/14/10/2563

Internet

https://www.mdpi.com/2072-6694/14/10/2563

Similar Items